Electrophoresis Transilluminator

Electrophoresis Transilluminator Market Outlook

The global electrophoresis transilluminator market is witnessing substantial growth, projected to reach USD 300 million by 2035, growing at a compound annual growth rate (CAGR) of approximately 6.5% during the forecast period from 2025 to 2035. This growth is spurred by the increasing prevalence of genetic and molecular biology research, as well as the expanding applications of electrophoresis in various sectors such as healthcare, pharmaceuticals, and biotechnology. Additionally, advancements in technology have led to the development of more efficient and user-friendly transilluminators, further propelling market demand. The growing emphasis on laboratory automation and increased funding for research activities are also contributing factors to the market's positive outlook. Moreover, the rising need for rapid and accurate results in drug discovery and development highlights the importance of electrophoresis techniques, thereby boosting the market growth.

Growth Factor of the Market

The growth of the electrophoresis transilluminator market can be attributed to several crucial factors that catalyze its expansion. One of the most significant drivers is the increasing adoption of molecular biology techniques in both academic and industrial laboratories, which necessitates the use of advanced electrophoresis equipment for analysis. Furthermore, the rise in research activities related to genomics and proteomics has necessitated the need for efficient gel imaging systems that can provide accurate results, leading to a surge in demand for transilluminators. The technological advancements in light sources, such as the transition from traditional UV to LED-based systems, have also enhanced the safety and ease of use, making them more appealing to researchers. Additionally, the global push towards personalized medicine and targeted therapies is driving investments in biopharmaceutical research, which in turn fuels the need for reliable electrophoresis methods. These growth factors collectively create a robust landscape for the electrophoresis transilluminator market.

Key Highlights of the Market

• The market is projected to reach USD 300 million by 2035, with a CAGR of 6.5% from 2025 to 2035.
• Technological advancements, particularly in LED technology, are transforming the landscape of transilluminators.
• Increased funding in genomics and proteomics research is driving the demand for electrophoresis equipment.
• The rising importance of personalized medicine is boosting research initiatives requiring gel imaging techniques.
• Safety concerns associated with traditional UV light sources are leading to a shift towards safer alternatives like LED.

By Product Type

UV Transilluminators:

UV transilluminators have long been the traditional choice for gel imaging in molecular biology, utilizing ultraviolet light to visualize nucleic acids and proteins in agarose gels. These instruments are particularly effective for detecting DNA and RNA, offering high sensitivity and resolution. However, they also pose certain risks due to the potential for UV exposure to laboratory personnel, which has led to increased scrutiny regarding their use. Despite these concerns, the UV transilluminator segment continues to dominate the market due to its established reliability and effectiveness, especially in research environments that prioritize traditional methodologies. The advancements in safety features, such as built-in protective shields and safety interlocks, are helping to mitigate some of these issues, thereby maintaining the popularity of UV-based systems in laboratories.

LED Transilluminators:

LED transilluminators are rapidly gaining traction in the market as they offer several advantages over traditional UV systems. The use of LED lighting technology significantly reduces the risk associated with UV exposure, making them a safer alternative for researchers. Additionally, LED transilluminators are known for their longer lifespan and lower energy consumption, which can lead to cost savings over time. Their ability to produce a range of wavelengths also allows for versatility in imaging various types of gels, making them suitable for a broader array of applications. As laboratories increasingly prioritize safety and sustainability, the demand for LED transilluminators is expected to grow significantly in the coming years.

White Light Transilluminators:

White light transilluminators provide an alternative method for visualizing gels, particularly when working with dyes that are sensitive to visible light. These systems do not have the harmful effects associated with UV exposure, thus ensuring a safer working environment for laboratory personnel. White light transilluminators are particularly useful for imaging applications involving proteins, where the use of coomassie blue or silver-stained gels is common. While their resolution and sensitivity may not match those of UV or LED systems, their ease of use and safety features make them an attractive choice for certain applications. The segment is experiencing growth as more labs begin to diversify their imaging capabilities and seek methods compatible with various staining techniques.

Blue Light Transilluminators:

Blue light transilluminators have emerged as a popular choice for gel imaging due to their ability to visualize nucleic acids stained with specific dyes that fluoresce under blue light. These systems offer a lower risk of DNA damage compared to traditional UV transilluminators, thus preserving the integrity of samples during analysis. In addition to being safer, blue light transilluminators typically deliver higher sensitivity for specific fluorescent dyes, making them a preferred choice among researchers working with applications that require precise detection. The growth of this segment is further propelled by the increasing use of fluorescence-based assays in genomic research, as well as the shift towards more user-friendly laboratory equipment.

Infrared Transilluminators:

Infrared transilluminators represent an innovative segment within the electrophoresis transilluminator market, leveraging infrared light for gel imaging. This method is particularly advantageous for researchers focused on applications requiring minimal background fluorescence, such as protein gel analysis. The ability to visualize samples without the associated drawbacks of UV or blue light makes infrared systems an appealing option for labs prioritizing sample preservation and accuracy in quantitative analysis. As research continues to evolve, the adoption of infrared transilluminators is expected to increase, particularly in specialized applications where traditional imaging methods may not suffice.

By Application

Nucleic Acid Gel Imaging:

Nucleic acid gel imaging is one of the cornerstone applications of electrophoresis transilluminators, as researchers rely on these systems to visualize DNA and RNA fragments following gel electrophoresis. The ability to accurately image nucleic acids is critical for downstream applications, such as cloning, sequencing, and genetic analysis. The growing emphasis on genomics and molecular diagnostics is driving significant investment in nucleic acid imaging technologies, leading to heightened demand for advanced transilluminators that provide high sensitivity and resolution. As the field of genetic research continues to expand, the nucleic acid gel imaging segment is likely to witness substantial growth, further underscoring the importance of electrophoresis transilluminators in laboratory settings.

Protein Gel Imaging:

Protein gel imaging is another vital application that drives the need for electrophoresis transilluminators. This application involves visualizing protein samples separated through electrophoresis, typically using techniques such as Western blotting or SDS-PAGE. As the biopharmaceutical industry continues to grow, the demand for robust and accurate methods for protein analysis is increasing. Electrophoresis transilluminators equipped with advanced imaging capabilities are essential for researchers developing new therapeutic proteins and antibodies, ensuring that they can analyze and characterize their samples effectively. The protein gel imaging segment is projected to expand as more laboratories incorporate these systems to meet the demands of proteomic research.

Southern Blot Analysis:

Southern blot analysis is a molecular biology technique used to detect specific DNA sequences within a complex sample, and it heavily relies on electrophoresis transilluminators for visualization. Researchers utilize this method to study gene expression, genetic variations, and the presence of specific genetic markers. The growth in genetic research and diagnostics is enhancing the demand for reliable Southern blot analysis tools, thereby increasing the need for efficient transilluminators. As the importance of genetic testing and molecular diagnostics continues to rise, the Southern blot analysis application segment is expected to see significant growth, reinforcing the relevance of electrophoresis techniques in modern laboratories.

Northern Blot Analysis:

Northern blot analysis, which involves the detection of RNA, is another critical application driving the electrophoresis transilluminator market. This technique is essential for studying gene expression at the transcriptional level, enabling researchers to assess the presence and size of specific RNA molecules. The increasing focus on transcriptomics and the role of non-coding RNAs in various biological processes is propelling the demand for Northern blot techniques. Transilluminators that offer high sensitivity and specificity for RNA detection are crucial for researchers in this field, leading to anticipated growth in this application segment as laboratories seek improved imaging modalities.

Western Blot Analysis:

Western blot analysis is a widely-used technique for protein detection and quantification, which relies on electrophoresis transilluminators for effective visualization of protein bands. This method is fundamental in various applications, including immunology, molecular biology, and diagnostics. The need for precise imaging of protein interactions and post-translational modifications is driving the demand for advanced transilluminators that can deliver high-resolution images. As the biopharmaceutical and diagnostic industries expand, the Western blot analysis segment is expected to thrive, emphasizing the importance of reliable imaging technologies in research and clinical laboratories.

By Distribution Channel

Online Stores:

Online stores have become an increasingly popular distribution channel for electrophoresis transilluminators, offering customers the convenience of purchasing equipment from the comfort of their laboratories. The rise of e-commerce platforms has made it easier for researchers to access a broader range of products and compare prices from different suppliers. Additionally, online sales often provide detailed product specifications and customer reviews, which can assist buyers in making informed decisions. This channel is expected to grow significantly as more laboratories embrace digital purchasing methods and seek to streamline their procurement processes. The convenience and efficiency of online shopping are driving researchers to opt for this distribution channel when acquiring transilluminators.

Laboratory Equipment Suppliers:

Laboratory equipment suppliers play a crucial role in the distribution of electrophoresis transilluminators, serving as trusted partners for research institutions and laboratories. These suppliers typically offer a curated selection of high-quality equipment, often accompanied by specialized services such as installation, maintenance, and training. The established relationships that suppliers maintain with manufacturers allow for efficient ordering and delivery processes, ensuring that researchers receive the products they need promptly. As laboratories continue to prioritize reliability and support in their equipment purchases, the market share of laboratory equipment suppliers is expected to remain robust, providing a consistent channel for transilluminator distribution.

Direct Sales:

Direct sales channels are also significant in the electrophoresis transilluminator market, as manufacturers often engage in selling products directly to end-users. This approach allows manufacturers to maintain control over pricing, product information, and customer service, ensuring a streamlined buying experience for researchers. Direct sales are particularly beneficial for high-value equipment like electrophoresis transilluminators, where buyers may require personalized consultation and support during the purchasing process. As manufacturers emphasize building strong relationships with their customers, the direct sales segment is poised to continue to be a key player in the market.

Others:

Other distribution channels encompass various methods of procuring electrophoresis transilluminators, including trade shows, scientific conferences, and partnerships with educational institutions. These channels present unique opportunities for manufacturers and suppliers to showcase their products and engage directly with potential customers. Trade shows and conferences allow researchers to explore new technologies, compare options, and receive hands-on demonstrations of products in a collaborative environment. Additionally, partnerships with educational institutions can facilitate bulk procurements and foster relationships that benefit both parties. As research communities grow, these alternative channels will continue to contribute to the overall landscape of the electrophoresis transilluminator market.

By Light Source

UV:

UV light sources have been the traditional standard in electrophoresis transilluminators, allowing for the visualization of nucleic acids and proteins based on their absorbance characteristics. The effectiveness of UV light in detecting DNA, RNA, and certain proteins makes it a widely utilized option in laboratories. However, the safety concerns associated with UV exposure have prompted laboratories to evaluate and adopt alternative lighting solutions that present fewer risks to personnel. Despite these challenges, UV light sources remain relevant in specific applications where sensitivity and resolution are paramount, ensuring their continued presence in the electrophoresis transilluminator market.

LED:

LED light sources are increasingly favored in electrophoresis transilluminators due to their reduced safety risks and enhanced energy efficiency. LED systems provide longer lifetimes compared to traditional UV sources, which translates to lower maintenance costs and minimal downtime in laboratory settings. The versatility of LED lighting enables researchers to utilize a range of wavelengths, accommodating various photochemical reactions and imaging requirements. As safety and sustainability become more critical priorities in laboratory environments, the adoption of LED light sources is expected to rise, driving growth in this segment.

White Light:

White light sources in electrophoresis transilluminators offer a non-harmful alternative for visualizing gels stained with specific dyes. These systems are particularly useful for imaging protein gels and other applications where traditional UV light may not be suitable. The advantage of using white light is that it poses no risk of damaging DNA or RNA samples, ensuring sample integrity during analysis. As laboratories continue to diversify their imaging techniques, white light sources represent a significant segment that caters to the need for safer and more versatile imaging solutions.

Blue Light:

Blue light sources have gained popularity in recent years, particularly for imaging nucleic acids stained with dyes that respond optimally to blue light wavelengths. These systems offer a safer alternative to UV transilluminators and have shown increased sensitivity for specific fluorescent dyes. The ability to visualize samples efficiently without the associated risks of UV exposure has made blue light transilluminators a preferred choice in many laboratories. As the demand for safe and effective imaging solutions grows, blue light sources are likely to see continued adoption within the electrophoresis transilluminator market.

Infrared:

Infrared light sources are an innovative addition to electrophoresis transilluminators, primarily used in applications that require minimal background fluorescence. These systems are ideal for protein gel imaging and quantitative analysis, as they provide a clear separation of bands with enhanced precision. The reduced risk of sample degradation and background interference makes infrared light sources an attractive option in environments where accuracy is critical. As research continues to evolve, the incorporation of infrared transilluminators is expected to increase, catering to specialized applications in the growing proteomics field.

By Region

The electrophoresis transilluminator market is characterized by significant regional variations, primarily driven by advancements in research infrastructure and funding in different areas. North America currently holds the largest share of the market, accounting for approximately 40% of the total revenue in 2025. The region is home to a multitude of leading research institutions and biotech companies that heavily invest in advanced laboratory equipment, including electrophoresis transilluminators. With a projected CAGR of 6.0% through 2035, North America is expected to sustain its dominance due to the continuous advancements in molecular biology research and the increasing demand for cutting-edge imaging technologies.

Europe follows closely behind, representing about 30% of the global market share in 2025 and projected to grow at a CAGR of 6.2% during the forecast period. The presence of well-established life sciences and biotechnology industries, along with increasing investments in genomics and proteomics research, significantly contributes to the region's growth. Furthermore, the European market is witnessing a shift toward safer and more efficient electrophoresis technologies, such as LED and infrared transilluminators, enhancing its competitive landscape. The Asia Pacific region is also emerging as a notable player, with a market share of approximately 20%, driven by the rising number of academic institutions and laboratories focused on research and development activities.

Opportunities

The electrophoresis transilluminator market presents numerous opportunities for growth and innovation, particularly as advancements in technology continue to reshape research methodologies. One significant opportunity lies in the development of multifunctional transilluminators that integrate multiple light sources, allowing researchers to utilize various imaging techniques within a single unit. This innovation would not only streamline laboratory workflows but also enhance the versatility of equipment, catering to a wider range of applications. As laboratories aim for increased efficiency and cost-effectiveness, the demand for such multipurpose systems is expected to rise, creating a robust market opportunity for manufacturers.

Another promising opportunity exists in the expanding applications of electrophoresis transilluminators beyond traditional research environments. As industries such as pharmaceuticals and biomanufacturing ramp up their operations, the need for reliable imaging technologies will extend into quality control and assurance processes. The integration of transilluminators in these sectors can facilitate enhanced protein analysis and characterization, ensuring that products meet stringent regulatory standards. Capitalizing on this trend, manufacturers can explore strategic partnerships with companies in related industries to expand their market reach and strengthen their product offerings.

Threats

Despite the considerable growth potential in the electrophoresis transilluminator market, several threats could impact its trajectory. One of the primary challenges is the rapid pace of technological advancements, which can render existing equipment obsolete. As newer and more efficient systems emerge, there is a risk that manufacturers may struggle to keep their product lines competitive. This challenge is exacerbated by the increasing expectation for higher performance and lower costs from consumers, which may compel smaller companies to exit the market or limit their product development efforts. To mitigate these risks, companies must invest in research and development to stay ahead of the curve and consistently offer innovative solutions that meet evolving market demands.

Another significant threat stems from the growing emphasis on safety and environmental regulations, which may impose constraints on the use of traditional UV transilluminators. As concerns regarding UV exposure and chemical safety rise, laboratories may seek alternatives that align better with regulatory standards. While this shift can lead to increased demand for safer technologies, it also means that manufacturers reliant on UV systems may face declining sales. In this context, companies must adapt by diversifying their product lines and investing in the development of safer alternatives to ensure long-term sustainability in the market.

Competitor Outlook

• Bio-Rad Laboratories
• Thermo Fisher Scientific, Inc.
• GE Healthcare
• Agilent Technologies, Inc.
• Amersham Biosciences
• Cleaver Scientific
• Lonza Group AG
• UVP, LLC (A part of Analytik Jena AG)
• VWR International, LLC
• Cell Signaling Technology, Inc.
• Syngene
• Harvard Bioscience, Inc.
• Bio-Techne Corporation
• Forensics Source
• Sciex

The competitive landscape of the electrophoresis transilluminator market is characterized by a mix of established players and emerging companies striving to capture a share of this expanding sector. Major companies such as Bio-Rad Laboratories and Thermo Fisher Scientific have established a strong foothold due to their extensive portfolios and commitment to research and development. These industry leaders continuously innovate, launching new products that cater to the evolving needs of researchers. The competition fosters an environment where technological advancements are rapidly integrated into new product offerings, providing laboratories with diverse options that enhance their research capabilities.

Additionally, companies like GE Healthcare and Agilent Technologies are making significant contributions to the market, leveraging their expertise in biotechnology and laboratory equipment. These firms focus on delivering high-quality transilluminators that meet rigorous performance standards, thus positioning themselves as reliable partners for research institutions. The ongoing emphasis on customer support and training also differentiates these companies from their competitors, ensuring that end-users maximize their equipment's potential. As the market evolves, these established players are well-equipped to navigate challenges and seize growth opportunities, maintaining their competitive advantage.

Emerging companies are also making their mark in the electrophoresis transilluminator market, often focusing on niche applications or innovative technologies. Firms such as Syngene and Cleaver Scientific are gaining traction by offering specialized products that cater to specific research areas, whether through advanced imaging capabilities or enhanced safety features. These companies are challenging the status quo and pushing for competitive pricing strategies to attract customers who may prioritize affordability alongside quality. As smaller players continue to innovate, they play a crucial role in diversifying the market landscape and encouraging established firms to evolve in response to changing demands.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Sciex
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Syngene
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Lonza Group AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Forensics Source
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Cleaver Scientific
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Amersham Biosciences
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bio-Rad Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Bio-Techne Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 VWR International, LLC
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Harvard Bioscience, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Agilent Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Cell Signaling Technology, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 UVP, LLC (A part of Analytik Jena AG)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Electrophoresis Transilluminator Market, By Application
    • 6.1.1 Nucleic Acid Gel Imaging
    • 6.1.2 Protein Gel Imaging
    • 6.1.3 Southern Blot Analysis
    • 6.1.4 Northern Blot Analysis
    • 6.1.5 Western Blot Analysis
  • 6.2 Electrophoresis Transilluminator Market, By Light Source
    • 6.2.1 UV
    • 6.2.2 LED
    • 6.2.3 White Light
    • 6.2.4 Blue Light
    • 6.2.5 Infrared
  • 6.3 Electrophoresis Transilluminator Market, By Product Type
    • 6.3.1 UV Transilluminators
    • 6.3.2 LED Transilluminators
    • 6.3.3 White Light Transilluminators
    • 6.3.4 Blue Light Transilluminators
    • 6.3.5 Infrared Transilluminators
  • 6.4 Electrophoresis Transilluminator Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Laboratory Equipment Suppliers
    • 6.4.3 Direct Sales
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Electrophoresis Transilluminator Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Electrophoresis Transilluminator market is categorized based on

By Product Type

• UV Transilluminators
• LED Transilluminators
• White Light Transilluminators
• Blue Light Transilluminators
• Infrared Transilluminators

By Application

• Nucleic Acid Gel Imaging
• Protein Gel Imaging
• Southern Blot Analysis
• Northern Blot Analysis
• Western Blot Analysis

By Distribution Channel

• Online Stores
• Laboratory Equipment Suppliers
• Direct Sales
• Others

By Light Source

• UV
• LED
• White Light
• Blue Light
• Infrared

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Bio-Rad Laboratories
• Thermo Fisher Scientific, Inc.
• GE Healthcare
• Agilent Technologies, Inc.
• Amersham Biosciences
• Cleaver Scientific
• Lonza Group AG
• UVP, LLC (A part of Analytik Jena AG)
• VWR International, LLC
• Cell Signaling Technology, Inc.
• Syngene
• Harvard Bioscience, Inc.
• Bio-Techne Corporation
• Forensics Source
• Sciex